Monoclonal Antibodies in Light of Mpox Outbreak: Current Research, Therapeutic Targets, and Animal Models

The rapid rise in monkeypox virus infections among humans from 2022 to 2024 has captured the attention of the global healthcare community. In light of the lack of mandatory vaccination and limited data on next-generation vaccines for monkeypox prevention, the urgent development of therapeutic agents...

Full description

Saved in:
Bibliographic Details
Main Authors: Vladimir N. Nikitin, Iuliia A. Merkuleva, Dmitriy N. Shcherbakov
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Antibodies
Subjects:
Online Access:https://www.mdpi.com/2073-4468/14/1/20
Tags: Add Tag
No Tags, Be the first to tag this record!